Early results from new PD-1 targeted immune therapy
2 Jun 2012
Early results from new PD-1 targeted immune therapy
Implementing symptom guidelines
Impact and management of malignant wounds
The evolving role of immunotherapy in oncology
Latest in renal carcinoma
Vemurafenib improves survival in melanoma with BRAF V600E mutation
Immunotherapy treatment for melanoma
Advances in the treatment of lung cancer and melanoma
Roundup of the EMCC 2011 conference
Genetic mutations as causes of cancer
Early detection and prevention of melanoma (6/6)
Guidelines and recommendations for advanced melanoma (5/6)